Výsledky vyhledávání - "Phillip H. Harris"

Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer sensitivity to gemcitabine

Autor: Kevin J. Church, Matthew Fagnan, Beatriz Mateo-Victoriano, Joseph W. Harding, Phillip H. Harris, Jewel C. LeValley, Rachelle R. Riggers, Brett R. Vanderwerff

Publikováno v: Anti-Cancer Drugs. 29:295-306

Pancreatic cancer is a leading cause of cancer deaths in the United States and is characterized by an exceptionally poor long-term survival rate compared to other major cancers. The hepatocyte growth factor (HGF) and macrophage stimulating protein (M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff89150c41e7472b7a98c8356a788df4
https://doi.org/10.1097/cad.0000000000000598

Zobrazit plný text záznamu

Abstract 926: The angiotensin IV analog Norleual acts as a hepatocyte growth factor/c-Met inhibitor in pancreatic cancer cells

Autor: John W. Wright, Phillip H. Harris, Leen H. Kawas, Kevin J. Church, Joseph W. Harding

Publikováno v: Cancer Research. 73:926-926

The primary purpose of this study was to demonstrate that the hepatocyte growth factor (HGF) antagonist Norleual is capable of attenuating the cellular responses of pancreatic cancer cells to HGF. The angiotensin IV analog Norleual [Nle-Tyr-Ile-ψ-(C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::83767a12ac84e5ef9bf86ebc062e47af
https://doi.org/10.1158/1538-7445.am2013-926

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání